SCHEMBL29655327

SCHEMBL29655327

CCCCCC(=O)[C@](C)(O)C(C)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.54
CES1 P23141 9/20 0.52
CES2 O00748 6/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CYP1A2 P05177 1/20 0.52
AKR1B1 P15121 1/20 0.44
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
TSHR P16473 3/20 0.43
GPR84 Q9NQS5 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871597 1.00 FAAH (0.54) FAAHCES1CES2MEN1KMT2A
SCHEMBL2862073 0.98 FAAH (0.55) FAAHCES1CES2MEN1KMT2A
SCHEMBL2871857 0.98 FAAH (0.55) FAAHCES1CES2MEN1KMT2A
SCHEMBL2863276 0.93 FAAH (0.45) FAAHCES1CES2MEN1KMT2A
SCHEMBL2860845 0.84 CES1 (0.39) FAAHCES1CES2MEN1KMT2A
SCHEMBL29487300 0.83 FAAH (0.54) FAAHCES1CES2MEN1KMT2A
SCHEMBL457471 0.81 FAAH (0.55) FAAHCES1CES2MEN1KMT2A
SCHEMBL2258518 0.81 FAAH (0.55) FAAHCES1CES2MEN1KMT2A
SCHEMBL1434843 0.81 FAAH (0.55) FAAHCES1CES2MEN1KMT2A
SCHEMBL2256117 0.81 FAAH (0.55) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 FAAH 2804/4885CES1 2831/4885CES2 1537/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 FAAH 2804/4885CES1 2831/4885CES2 1537/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 FAAH 2804/4885CES1 2831/4885CES2 1537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.